12-year-old Boy from Waterloo, Iowa Wins American Kidney Fund National Art Contest for Pediatric Kidney Patients
06 oct. 2022 11h10 HE
|
American Kidney Fund
ROCKVILLE, Md., Oct. 06, 2022 (GLOBE NEWSWIRE) -- A young kidney transplant recipient from Waterloo, IA has won the American Kidney Fund’s (AKF) 27th annual national Calendar Kids Art Contest....
Eledon Pharmaceuticals to Participate in Two Upcoming Conferences
03 oct. 2022 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming conferences: A...
American Kidney Fund’s New APOL1-Mediated Kidney Disease Campaign Aims to Educate and Increase Awareness About APOL1 Gene Mutations
27 sept. 2022 08h57 HE
|
American Kidney Fund
ROCKVILLE, Md., Sept. 27, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched its new APOL1 campaign, which aims to educate and increase awareness about APOL1-mediated kidney...
Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
22 sept. 2022 16h05 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that David-Alexandre C. Gros, Chief Executive Officer, will participate in...
Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2022 Corporate Membership Program at ‘Champion’ Level
19 sept. 2022 11h27 HE
|
American Kidney Fund
ROCKVILLE, Md., Sept. 19, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim and Eli Lilly and Company have joined the 2022 class in AKF’s Corporate...
American Kidney Fund, Home Dialyzors United Partner to Host Dialysis at Home Summit
13 sept. 2022 16h26 HE
|
American Kidney Fund
ROCKVILLE, Md., Sept. 13, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has partnered with Home Dialyzors United, a nonprofit advocating on behalf of the home dialyzor community, to host...
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy
06 sept. 2022 16h01 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's...
Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29 août 2022 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming investor...
Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results
11 août 2022 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Received FDA clearance of IND application for Phase 2 trial evaluating tegoprubart for the prevention of rejection in kidney transplant recipients First patient dosed in Phase 1b trial evaluating...
Eledon Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
04 août 2022 16h05 HE
|
Eledon Pharmaceuticals, Inc.
Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical...